Pierre Morel

15PUBLICATIONS
73CO-AUTHORS
Medical mycologyTumour immunologyHumoural immunology and immunochemistryRegenerative medicine (incl. stem cells)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jan 07, 2026
POD24 is a novel determinant of prognosis in patients with Waldenström macroglobulinemia.

Saurabh Zanwar, Jithma Abeykoon, Shirley D'Sa

|Oct 07, 2025
Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.

David Vallois, Edoardo Missiaglia, Luis Veloza

|Mar 20, 2025
Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real-World Analysis.

Thomas Hueso, Grégory Lazarian, Paul Chauvet

|Nov 13, 2023
Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational study.

Laurent Garderet, Hafida Ouldjeriouat, Mohamed-Amine Bekadja

|Feb 10, 2023
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia.

Christian Buske, Meletios A Dimopoulos, Alexander Grunenberg

|Nov 26, 2022
Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia.

Irene Dogliotti, Cristina Jiménez, Marzia Varettoni

Pageof 3

Frequent Collaborators

6 joint publications

Damien Roos-Weil

4 joint publications

Meletios Athanasios Dimopoulos

4 joint publications

Olivier Tournilhac

4 joint publications

Efstathios Kastritis